Brief introduction to the protective isolation cabin project of Heilongjiang Blue Salt Particle Technology Co., Ltd. Heilongjiang Blue Salt Particle Technology Co., Ltd. was established on August 13, 2019, and officially settled in the Jiamusi High-tech Zone Innovation and Entrepreneurship Service Center on January 16, 2020. Heilongjiang Blue Salt Microparticle Technology Co., Ltd. is committed to medical technology promotion services, medical equipment and R&D and production, salt therapy product technology development services, research and development, production, sales and after-sales maintenance of protective isolation cabins. On March 5, 2020, in the most difficult situation of the epidemic, the company began to develop a protective isolation chamber. And on April 1st, the country’s first protective isolation cabin was successfully developed. It was successfully tested in Jiamusi Maternity and Child Health Hospital. After testing and improving some functions, through continuous improvement, a total of three generations of products have been developed, namely, the 1.0 version of the protective isolation cabin. , Protective isolation cabin version 2.0, protective isolation cabin version 3.0, from the beginning only the positive pressure cabin to protect the medical staff to the protective isolation cabin that both protects the medical staff and protects the positive and negative pressure of the subject, now the protective isolation cabin Versions 1.0, 2.0, and 3.0 are playing an active role in epidemic prevention on the front line, with hospitals and customs in the three eastern provinces as far away as Xinjiang. After the product is successfully developed, we pay attention to the detection of product functions and the protection of product property rights. On June 23 and September 26, 2020, relevant experts organized by Jiamusi Industrial Technology Research Institute Co., Ltd. carried out the protective isolation cabin. The identification was confirmed, and the result was confirmed: “The product has complete technical documents, specifications, meets identification requirements, and complies with relevant national standards and regulations, and plays an active role in preventing epidemics and public safety and health incidents.” July 11, 2020, September 2020 On the 28th, Heilongjiang Xingzheng Testing Technology Co., Ltd. conducted a total of 16 tests on the relevant technical parameters of the protective compartment, and the results met the requirements of the GB19489-2008 standard. It has applied for patents for the products three times, and has applied for three invention patents and three utility model patents. The company has not stopped the strict requirements for products. The company has applied for the second-class medical device production license to the provincial drug regulatory department on October 27, 2020. It is now under review. After the review, the protective isolation compartment produced by our company will be Become a medical product and be used as the first line of protection in hospitals. The company is a small and micro enterprise, and because the company has not been established recently, the company does not have much experience in management, and basically does not have its own R&D team in terms of (research) personnel. The core team, on the equipment of the production workshop, can only meet the existing manual manufacturing standards, and failed to form large-scale mass production. The current output is 10 units per month. The production volume cannot meet the needs of the current epidemic. The current production situation can only Order production. Insufficient funds and disadvantages are particularly obvious. To a certain extent, the company’s expansion and advancement are bothering the company’s pace of expansion. Especially now the development of R&D personnel, materials, equipment costs, etc. is very slow, and there are even many reasons. Funding problems cannot be carried out, such as market operations so far without a professional person doing it. contact us